MedTrace Logo

Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer

NCT03963739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2025-07-16

No results posted yet for this study

Summary

The objective of this study is to examine how adenocarcinoma of the prostate treatment differentially affects African American men's ability to work and to describe and compare changes in work ability (as measured through self-reported global work ability item) reported by African American and white adenocarcinoma of the prostate survivors before treatment and 6 months after treatment completion.

Conditions

  • Prostate Adenocarcinoma
  • Stage I Prostate Cancer
  • Stage II Prostate Cancer
  • Stage III Prostate Cancer

Interventions

OTHER

Interview

Undergo interview

OTHER

Questionnaire Administration

Ancillary studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Glenn Lesser, MD · Wake Forest University Health Sciences

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-19
Primary Completion
2025-03-25
Completion
2025-03-25

Countries

  • United States
  • Guam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03963739 on ClinicalTrials.gov